3AI Holding – SML partnership aims to reach 200 million users in 22 Indian languages within the first year of launch. (Photo posted by @ArjunPrasad_QX on X)
Abu Dhabi investment firm 3AI Holding and SML India on Thursday announced a partnership to jointly own ‘Hanooman’, a multilingual generative artificial intelligence (GenAI) platform launching on May 1.
SML, short for Seetha Mahalaxmi Healthcare, introduced Hanooman at the Nasscom National Technology Leadership Forum Techade conference in February. 3AI Holding’s proprietary Omega GenAI technology will make Hanooman “bigger and more powerful”, said the companies which will each hold 50 per cent in the platform.
Our endeavor, at @3AIHolding , has been to push the boundaries of AI innovation. Our partnership with Seetha Mahalaxmi Healthcare’s (SML) @Hanooman_ai is a step towards the shared vision to provide equitable AI access and enhance human well-being and societal development.
— Arjun Prasad (@ArjunPrasad_QX) April 4, 2024
As many as 80 per cent of India’s 1.42 billion people does not speak English. Hanooman will offer multimodal and multilingual capabilities, including text, voice, images, and codes to users. It will enable GenAI platforms to build their applications and can be used by startups.
3AI Holding Limited, which is led by Arjun Prasad, is developing an advanced version of Omega to compete with global GenAI platforms. 3AI is backed by the Patel Family Office in the United States.
First Published: Apr 04 2024 | 3:36 PM IST
